Bellicum Completes Sale of Houston Facility Read more about Bellicum Completes Sale of Houston Facility
Bellicum Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Operational Update Read more about Bellicum Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Operational Update
Bellicum to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update Read more about Bellicum to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read more about Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Bellicum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Read more about Bellicum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Bellicum Presents New Translational Data for BPX-601 at ASCO GI Cancers Symposium Read more about Bellicum Presents New Translational Data for BPX-601 at ASCO GI Cancers Symposium
Bellicum Pharmaceuticals Enters into Asset Purchase and Master Services Agreements with MD Anderson Read more about Bellicum Pharmaceuticals Enters into Asset Purchase and Master Services Agreements with MD Anderson
Bellicum Pharmaceuticals to Present New Translational Data for BPX-601 at ASCO 2020 Gastrointestinal Cancers Symposium Read more about Bellicum Pharmaceuticals to Present New Translational Data for BPX-601 at ASCO 2020 Gastrointestinal Cancers Symposium